Publications
554
Citations
23,889
Est. group size
—
Recurring co-author estimate
Active years
57
Publishing since 1970
David Dunn conducts research in clinical medicine with a strong focus on HIV/AIDS, including prevention strategies such as pre-exposure prophylaxis (PrEP), HIV testing, treatment approaches, and the statistical design of clinical trials. The work spans large randomized trials and observational studies, and also touches on genomics of infectious diseases and, in some publications, childhood epilepsy. The research often applies advanced trial methodology (for example, non-inferiority trial design) to real-world health questions.
Publication activity has been fairly steady over the last decade, averaging around 10-14 papers per year with a peak in 2018.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Cognitive and behavioral comorbidities of childhood epilepsy
Developmental Medicine & Child Neurology · 2026
- Medication reference tables for neurologists: A focus on psychotropic medications in epilepsy
Epilepsy & Behavior Reports · 2025
- Evidence for circulation of high-virulence HIV-1 subtype B variants in the United Kingdom
Virus Evolution · 2025
- Evaluating adherence in an active-controlled HIV pre-exposure prophylaxis trial (PrEPVacc) to inform the estimation of HIV incidence in a counterfactual placebo arm
HIV Research & Clinical Practice · 2025
- A Comparison of F/TAF and F/TDF as HIV Pre-Exposure Prophylaxis in a Predominantly Cisgender Women Population in East and South Africa: A Randomised, Factorial, Non-Inferiority Trial
SSRN Electronic Journal · 2025
- Prevalence and factors associated with use of prophylaxis for HIV and sexually transmitted infections among sexual health service attendees in England: findings from a cross-sectional observational study
medRxiv · 2025
- Sample size estimation for the averted events ratio
Clinical Trials · 2025
- Exploring different objectives in non-inferiority trials
BMJ · 2024
- High-resolution genomics identifies pneumococcal diversity and persistence of vaccine types in children with community-acquired pneumonia in the UK and Ireland
BMC Microbiology · 2024
- MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIV
AIDS · 2024
- Needs & networks: understanding the role and impact of social networks on HIV (self-)testing among GBMSM and trans people in England and Wales
BMC Public Health · 2024
- Long-term efficacy and safety of a treatment strategy for HIV infection using protease inhibitor monotherapy: 8-year routine clinical care follow-up from a randomised, controlled, open-label pragmatic trial (PIVOT)
EClinicalMedicine · 2024
- Assessing Whether Providing Regular, Free HIV Self-Testing Kits Reduces the Time to HIV Diagnosis: An Internet-Based, Randomized Controlled Trial in Men Who Have Sex With Men
JAIDS Journal of Acquired Immune Deficiency Syndromes · 2024
- Challenges in estimating the counterfactual placebo HIV incidence rate from a registration cohort: The PrEPVacc trial
Clinical Trials · 2024
- Characterizing latent sleep phenotype trajectories over 36 months in children with new-onset seizures
Sleep Medicine · 2024
- HIV Medicine×9
- AIDS×8
- The Lancet HIV×8
- Journal of Antimicrobial Chemotherapy×6
- SSRN Electronic Journal×6
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile